Hépato-Gastro & Oncologie Digestive
Agenda
Volume 29, supplement 3, August 2022
News from the JFHOD 2022 and new therapeutic developments in the management of advanced cholangiocarcinoma and other digestive cancers
Numéro réalisé avec le soutien institutionnel des laboratoires Incyte et Servier
Volume 29, supplement 3, August 2022
Synthèse des communications
New therapeutic options in biliary tract cancer: How to improve molecular profiling and access to personnalized medicine
(p.5-14)
Gael Roth
Digestive tumors: What novelties in therapeutic sequences?
(p.15-23)
Claire Gallois
JFHOD 2022: Highlights in digestive oncology (onco-immunology excluded)
(p.25-35)
Violaine Randrian